Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Cropley

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bailliere'S Best Practice & Research. Clinical Gastroenterology|July 13, 2000
Hepatitis C virus infection: co-infection with HIV and HBVI Cropley, J Main
Vaccine|January 1, 1993
Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHAM Roberts, I Cropley, S Chatfield, et al.
Thorax|January 20, 2000
Tuberculosis diagnosed during pregnancy: a prospective study from LondonM Llewelyn, I Cropley, R J Wilkinson, et al.
Acute Medicine|March 17, 2012
Endogenous endophthalmitis and liver abscessesS Koay, S Jain, I Cropley, et al.
FEMS Immunology and Medical Microbiology|June 1, 1993
The development of oral vaccines based on live attenuated Salmonella strainsS Chatfield, M Roberts, P Londono, et al.
Vaccine|December 1, 1995
Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatmentI Cropley, G Douce, M Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsG Douce, C Turcotte, I Cropley, et al.
The Journal of Infection|December 3, 2014
Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysisJ Sewell, S Capocci, J Johnson, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 5, 2008
How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis?R A M Breen, O Leonard, F M R Perrin, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bailliere'S Best Practice & Research. Clinical Gastroenterology|July 13, 2000
Hepatitis C virus infection: co-infection with HIV and HBVI Cropley, J Main
Vaccine|January 1, 1993
Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHAM Roberts, I Cropley, S Chatfield, et al.
Thorax|January 20, 2000
Tuberculosis diagnosed during pregnancy: a prospective study from LondonM Llewelyn, I Cropley, R J Wilkinson, et al.
Acute Medicine|March 17, 2012
Endogenous endophthalmitis and liver abscessesS Koay, S Jain, I Cropley, et al.
FEMS Immunology and Medical Microbiology|June 1, 1993
The development of oral vaccines based on live attenuated Salmonella strainsS Chatfield, M Roberts, P Londono, et al.
Vaccine|December 1, 1995
Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatmentI Cropley, G Douce, M Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsG Douce, C Turcotte, I Cropley, et al.
The Journal of Infection|December 3, 2014
Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysisJ Sewell, S Capocci, J Johnson, et al.
Infection and Immunity|June 1, 1995
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsM Roberts, A Bacon, R Rappuoli, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 5, 2008
How good are systemic symptoms and blood inflammatory markers at detecting individuals with tuberculosis?R A M Breen, O Leonard, F M R Perrin, et al.
Pageof 2